Component: (Network and Table) | |
---|---|
Network | 00400 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS (http://la-z-boy.com/role/StatementConsolidatedStatementOfCashFlows) |
Table | (Implied) |
Reporting Entity [Axis] | 0000057131 (http://www.sec.gov/CIK) |
CONSOLIDATED STATEMENT OF CASH FLOWS | Period [Axis] | ||
---|---|---|---|
2015-04-26 - 2016-04-30 | 2014-04-27 - 2015-04-25 | 2013-04-28 - 2014-04-26 | |
CONSOLIDATED STATEMENT OF CASH FLOWS | |||
Cash flows from operating activities | |||
Net income | 80,963,000 | 71,971,000 | 56,380,000 |
Adjustments to reconcile net income to cash provided by operating activities | |||
(Gain) loss on disposal of assets | ( | ||
Gain on sale of investments | ( | ( | ( |
Write-down of long lived assets | |||
Deferred income tax expense (benefit) | ( | ||
Restructuring | ( | ||
Provision for doubtful accounts | ( | ( | ( |
Depreciation and amortization | |||
Stock-based compensation expense | |||
Pension plan contributions | ( | ||
Change in receivables | ( | ||
Change in inventories | ( | ( | ( |
Change in other assets | ( | ||
Change in accounts payable | ( | ( | |
Change in other liabilities | ( | ( | |
Net cash provided by operating activities | |||
Cash flows from investing activities | |||
Proceeds from disposals of assets | |||
Proceeds from sale of business | |||
Capital expenditures | ( | ( | ( |
Purchases of investments | ( | ( | ( |
Proceeds from sales of investments | |||
Acquisitions, net of cash acquired | ( | ( | ( |
Change in restricted cash | |||
Net cash used for investing activities | ( | ( | ( |
Cash flows from financing activities | |||
Payments on debt | ( | ( | ( |
Payments for debt issuance costs | ( | ||
Stock issued for stock and employee benefit plans | |||
Excess tax benefit on stock option exercises | |||
Purchases of common stock | ( | ( | ( |
Dividends paid | ( | ( | ( |
Net cash used for financing activities | ( | ( | ( |
Effect of exchange rate changes on cash and equivalents | ( | ( | ( |
Change in cash and equivalents | ( | ||
Cash and equivalents at beginning of period | 98,302,000 | ||
Cash and equivalents at end of period | 112,358,000 | 98,302,000 | 149,661,000 |
Supplemental disclosure of non-cash investing activities | |||
Capital expenditures included in payables |